Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vogler

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Cancer|March 15, 1989
High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study GroupH M Lazarus, W R Vogler, C P Burns, et al.
Archives of Internal Medicine|May 1, 1980
Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factorE H Hirsh, W R Vogler, T P McDonald, et al.
The American Journal of the Medical Sciences|March 1, 1972
Septicemia due to Aeromonas hydrophila and Mima polymorpha in a patient with acute myelogenous leukemiaR R Gifford, D W Lambe, S D McElreath, et al.
Cancer Treatment Reports|December 1, 1977
Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II studyE Vélez-Garcia, W R Vogler, A A Bartolucci, et al.
Biochemical and Biophysical Research Communications|March 29, 1983
Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophilsD M Helfman, B D Appelbaum, W R Vogler, et al.
Biochemical Pharmacology|October 15, 1985
Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovaryH D Su, G J Mazzei, W R Vogler, et al.
Cancer Investigation|December 9, 1998
The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivoW R Vogler, J Liu, O Volpert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3F J Candal, D C Bosse, W R Vogler, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1972
Granulopoietic stem cell regulators in murine urine: alterations in activity after methotrexateW R Vogler, E S Mingioli, F A Garwood, et al.
Experimental Hematology|July 1, 1981
Temporal correlation of the marrow's production of granulopoietic stimulatory activity and granulocyte regeneration after vinblastineE F Winton, W R Vogler, M B Parker, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Cancer|March 15, 1989
High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study GroupH M Lazarus, W R Vogler, C P Burns, et al.
Archives of Internal Medicine|May 1, 1980
Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factorE H Hirsh, W R Vogler, T P McDonald, et al.
The American Journal of the Medical Sciences|March 1, 1972
Septicemia due to Aeromonas hydrophila and Mima polymorpha in a patient with acute myelogenous leukemiaR R Gifford, D W Lambe, S D McElreath, et al.
Cancer Treatment Reports|December 1, 1977
Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II studyE Vélez-Garcia, W R Vogler, A A Bartolucci, et al.
Biochemical and Biophysical Research Communications|March 29, 1983
Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophilsD M Helfman, B D Appelbaum, W R Vogler, et al.
Biochemical Pharmacology|October 15, 1985
Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovaryH D Su, G J Mazzei, W R Vogler, et al.
Cancer Investigation|December 9, 1998
The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivoW R Vogler, J Liu, O Volpert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3F J Candal, D C Bosse, W R Vogler, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1972
Granulopoietic stem cell regulators in murine urine: alterations in activity after methotrexateW R Vogler, E S Mingioli, F A Garwood, et al.
Experimental Hematology|July 1, 1981
Temporal correlation of the marrow's production of granulopoietic stimulatory activity and granulocyte regeneration after vinblastineE F Winton, W R Vogler, M B Parker, et al.
Pageof 19